Recent Research
Jefferson’s CEO Joseph G. Cacchione, MD is pleased to announce that John P. Mordach, has been named Executive Vice President and Chief Financial Officer of Jefferson, which consists of Thomas Jefferson University, Jefferson Health and Health Partners Plans. Effective March 20, 2023, Mordach will join the organization from Duke University Health System (DUHS) where he served as Senior Vice President, CFO and Treasurer for the $4.5 billion academic health system since 2020.
With a projected 2.5 billion more people living in cities by 2050, the need to design sustainable cities has never been greater.
Researchers discover a potential therapeutic avenue against an aggressive form of prostate cancer.
New research into making asthma and COPD medication more potent could also improve how long they work in patients who need frequent doses.
Exploring the ways technology can improve collaborative treatment approaches for patients with opioid use disorder.
This year marks five years since the historic merger of two celebrated Philadelphia institutions — Thomas Jefferson University (Jefferson), a health sciences university that was founded in 1824 as the Jefferson Medical College, and Philadelphia University, a regional masters university and the nation’s first textile school founded in 1884.
The device improves upper limb function for patients with disability after stroke by stimulating the vagus nerve during rehab training.
Additional insights can help guide interventions that can assist individuals in processing and understanding their surroundings better.
Understanding how war and displacement complicate gender and sexuality in Afghanistan and its diaspora.
Long-non-coding RNA as a common driving force in cancer, blood analysis reveals COVID-19 risks, and a common drug finds a new application.
For news not listed on this page view the Jefferson News Archive.